{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458273717
| IUPAC_name = 人 β-[[葡萄糖脑苷脂酶|葡萄糖脑苷脂酶]]
| image = 
<!-- Clinical data -->
| tradename = Cerezyme
| Drugs.com = {{drugs.com|monograph|imiglucerase}}
| MedlinePlus = a601149
| licence_EU = yes
| licence_US = Imiglucerase
| pregnancy_category = 
| legal_US = Rx-only
| routes_of_administration = [[靜脈注射|靜脈注射]]
<!-- Pharmacokinetic data -->
| bioavailability = 
| protein_bound = 
| metabolism = 主要是[[蛋白酶解|蛋白酶解]]
| elimination_half-life = 3.6–10.4 分钟
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|changed|CAS}}
| CAS_number = 154248-97-2
| ATC_prefix = A16
| ATC_suffix = AB02
| ATC_supplemental = 
| PubChem = 
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00053
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Q6U6J48BWY
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02810
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201632
<!-- Chemical data -->
| C=2532 | H=3854 | N=672 | O=711 | S=16
| molecular_weight = 55597.4 (un[[glycosylate|glycosylate]]d)
}}
'''伊米苷酶'''（商品名：思而赞，英文名称：Cerezyme）是由赛诺菲研发1994年在美国上市，罕见病[[戈谢病|戈谢病]]注射剂特效药。2009年开始，思而赞进入中国大陆。
一瓶思而赞是400单位。戈谢病治疗时需终身注射“思而赞”，一支就要2万余元。以5岁的小孩为例每月需打4针，每年花费近100万元。“思而赞”尚未列入基本医保目录。但2016年缙云县将思而赞纳入当地罕见病用药保障，每年上百万元的医疗费用，个人只需自付3万元。
<ref>http://gongyi.people.com.cn/n1/2019/0315/c151132-30977804.html</ref>
<ref>{{Cite web |url=http://www.infzm.com/contents/174670 |title=存档副本 |access-date=2020-09-09 |archive-date=2020-01-30 |archive-url=https://web.archive.org/web/20200130232919/http://www.infzm.com/contents/174670 |dead-url=no }}</ref>
<ref>https://baijiahao.baidu.com/s?id=1672333366104769490</ref>
<ref>https://baijiahao.baidu.com/s?id=1673787559141330702</ref>
<ref>http://xhv5.xhby.net/mp3/pc/c/202001/15/c737667.html</ref>

==参看==
*[[孤儿药|孤儿药]]

==参考文献==
{{reflist}}
{{其它消化道和代谢药物}}

[[Category:罕见疾病|Category:罕见疾病]]
[[Category:罕用药|Category:罕用药]]